ValueAct Capital Management, LLC is Director at Valeant Pharmaceuticals International, Inc. (VRX). They have made 48 open-market trades across 22 companies since 2006, most recently 2024-12-20.
CIK 0001351073
26 open-market purchases totalling $333.8M since 2006, against 22 sales. Across 18 scored buys the stock is up 3.8% at ninety days, and 2.1 points ahead of the S&P over the same stretch.
18 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 39% | 78% | 78% |
| Avg Move | -4.6% | +1.9% | +3.8% |
| Alpha | -2.4% | +3.1% | +2.1% |
| Scored | 18 | 18 | 18 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 59% | 41% | 45% |
| Avg Move | -1.3% | +2.3% | +2.2% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRM | SELL | 2024-12-18 | 2024-12-20 | $343.69 | $450.0M | -2.7% | -4.5% | -18.5% |
| NSIT | SELL | 2024-05-29 | 2024-05-31 | $192.49 | $86.6M | +1.0% | +1.2% | +9.8% |
| NSIT | BUY | 2023-02-17 | 2023-02-22 | $129.99 | $962K | +4.8% | +7.3% | +1.3% |
| NSIT | BUY | 2022-08-22 | 2022-08-24 | $94.05 | $17.4M | -10.5% | -11.8% | +9.9% |
| NSIT | BUY | 2022-05-18 | 2022-05-20 | $98.46 | $11.6M | +1.6% | -11.4% | -2.4% |
| NSIT | BUY | 2022-05-10 | 2022-05-12 | $97.80 | $15.6M | -2.6% | -3.2% | -6.6% |
| TRN | SELL | 2022-02-22 | 2022-02-24 | $28.45 | $107.5M | +11.0% | +22.8% | -15.8% |
| STX | SELL | 2021-04-30 | 2021-05-04 | $90.28 | $520.8M | +9.7% | +9.2% | -0.9% |
| STX | SELL | 2021-03-03 | 2021-03-05 | $72.75 | $676.6M | +5.7% | +7.4% | +32.3% |
| AES | BUY | 2020-06-11 | 2020-06-15 | $12.22 | $6.1M | +2.2% | +11.0% | +32.2% |
| TRN | BUY | 2020-01-27 | 2020-01-29 | $20.85 | $5.9M | +1.9% | -2.3% | -16.1% |
| UFI | BUY | 2019-09-03 | 2019-09-05 | $18.95 | $138K | +16.7% | +9.1% | +24.8% |
| ACA | SELL | 2019-06-12 | 2019-06-14 | $36.03 | $54.0M | -0.1% | -2.9% | -5.6% |
| STX | BUY | 2019-02-06 | 2019-02-08 | $44.90 | $99.9M | -0.5% | +7.2% | +4.9% |
| TRN | BUY | 2017-11-02 | 2017-11-06 | $31.98 | $722K | +2.9% | +9.5% | -0.8% |
| WLTW | SELL | 2017-08-31 | 2017-09-05 | $148.64 | $32.1M | +3.6% | +5.1% | +7.3% |
| WLTW | SELL | 2017-08-07 | 2017-08-09 | $149.59 | $122.7M | +0.3% | +2.3% | +8.9% |
| WLTW | SELL | 2017-05-17 | 2017-05-19 | $140.55 | $253.0M | +4.5% | +6.6% | +5.5% |
| CBG | SELL | 2017-05-11 | 2017-05-15 | $35.20 | $528.0M | -0.5% | +2.6% | +4.3% |
| MSFT | SELL | 2017-02-21 | 2017-02-23 | $64.40 | $305.5M | -0.1% | +1.0% | +6.7% |
| CBG | BUY | 2016-10-28 | 2016-11-01 | $25.80 | $49.9M | +6.5% | +13.4% | +16.0% |
| MSCI | SELL | 2016-09-09 | 2016-09-13 | $85.41 | $19.2M | +1.5% | -3.7% | -5.5% |
| MSCI | SELL | 2016-06-14 | 2016-06-16 | $74.60 | $12.7M | -0.4% | +9.5% | +14.3% |
| MSCI | SELL | 2016-05-02 | 2016-05-04 | $75.16 | $22.4M | +0.1% | +3.0% | +13.2% |
| MSCI | SELL | 2015-11-30 | 2015-12-02 | $69.98 | $45.5M | -4.7% | -0.7% | +0.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| MSCI | 625,900 | $356.1M |
| IT | 1,648,434 | $338.5M |
| AES | 5,346,500 | $79.9M |
| KAR | 2,058,828 | $63.6M |
| UFI | 1,417,054 | $8.0M |
| PSTI | 5,793,073 | $5.8M |
| TRN | 90,847 | $2.3M |
| AWI | 8,349 | $1.4M |
| FOX | 17,311 | $991K |
| ADBE | 3,986 | $978K |
| VRX | 35,493 | $831K |
| MSFT | 589 | $312K |
| FISV | 4,463 | $212K |
| BHC | 9,885 | $62K |
| LKQ | 2,340 | $52K |
| SLE | 4,812 | $21K |
| OCR | 5,619 | — |
| MNT | 4,083,333 | — |
| HC | 9,496,200 | — |
| GVHR | 14,135 | — |
| BLUD | 5,755,779 | — |
| REY | 7,774,500 | — |
| WSH | 18,214,700 | — |
| Total | $7.7B |
Shares reported on the most recent Form 4, priced at the 2024-12-20 close. 7 holdings could not be priced and are excluded from the total.
| Scored | 22 | 22 | 22 |